全文获取类型
收费全文 | 1453篇 |
免费 | 128篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 70篇 |
妇产科学 | 18篇 |
基础医学 | 97篇 |
口腔科学 | 3篇 |
临床医学 | 314篇 |
内科学 | 547篇 |
皮肤病学 | 18篇 |
神经病学 | 56篇 |
特种医学 | 16篇 |
外科学 | 202篇 |
综合类 | 117篇 |
现状与发展 | 1篇 |
预防医学 | 17篇 |
眼科学 | 26篇 |
药学 | 43篇 |
1篇 | |
中国医学 | 25篇 |
肿瘤学 | 29篇 |
出版年
2023年 | 32篇 |
2022年 | 50篇 |
2021年 | 81篇 |
2020年 | 63篇 |
2019年 | 58篇 |
2018年 | 68篇 |
2017年 | 50篇 |
2016年 | 43篇 |
2015年 | 52篇 |
2014年 | 86篇 |
2013年 | 92篇 |
2012年 | 64篇 |
2011年 | 74篇 |
2010年 | 54篇 |
2009年 | 54篇 |
2008年 | 67篇 |
2007年 | 61篇 |
2006年 | 59篇 |
2005年 | 51篇 |
2004年 | 63篇 |
2003年 | 39篇 |
2002年 | 38篇 |
2001年 | 28篇 |
2000年 | 25篇 |
1999年 | 19篇 |
1998年 | 24篇 |
1997年 | 19篇 |
1996年 | 18篇 |
1995年 | 14篇 |
1994年 | 17篇 |
1993年 | 10篇 |
1992年 | 10篇 |
1991年 | 5篇 |
1990年 | 9篇 |
1989年 | 8篇 |
1988年 | 11篇 |
1987年 | 5篇 |
1986年 | 6篇 |
1985年 | 7篇 |
1984年 | 11篇 |
1983年 | 8篇 |
1982年 | 10篇 |
1981年 | 4篇 |
1980年 | 7篇 |
1979年 | 2篇 |
1978年 | 6篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1973年 | 3篇 |
1970年 | 4篇 |
排序方式: 共有1601条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
Michael Robson Isabelle Côte Ian Abbs Geoffrey Koffman David Goldsmith 《American journal of transplantation》2003,3(3):324-327
Thrombotic microangiopathy is a rare but important finding in the context of organ transplantation. Acute renal insufficiency in the setting of hemolysis and thrombocytopenia, a triad that constitutes 'hemolytic uremic syndrome', can be associated with, or triggered by, conditions such as verocytotoxin-producing Escherichia coli, viral infections, malignant hypertension, scleroderma, allograft rejection, lupus erythematosus, pregnancy, and medications including mitomycin C, calcineurin inhibitors, and oral contraceptives. After renal transplantation, it can occur, as either a de novo episode, or recurrent disease. Calcineurin inhibitors have long been associated with post-transplantation thrombotic microangiopathy. Sirolimus has been used as a primary immunosuppressant in patients transplanted with a history of earlier hemolytic-uremic syndrome, and also as rescue therapy in patients with calcineurin-inhibitor-associated thrombotic microangiopathy. We describe four cases where there was significant thrombotic microangiopathy in the context of contemporaneous or contiguous calcineurin inhibitor and sirolimus usage. As the intrarenal cyclosporin concentration is thought to be significantly elevated when cyclosporin and sirolimus are used together, this may explain these findings, and mandates caution in their co-administration. 相似文献
6.
Six patients with prolonged acute courses of thrombotic microangiopathy are reviewed. These patients had in common courses of acute disease requiring plasma support for more than 3 months, with subsequent complete remission. Plasma support requirements may be prodigious, and the acute course may require more than 100 plasma exchanges before a stable remission is achieved. These patients appear to represent a subset of thrombotic microangiopathy distinct from the more common acute T.T.P. course, which resolves in 3–6 weeks, and the chronic relapsing pattern, which may have a short or prolonged acute course. © 1992 Wiley-Liss, Inc. 相似文献
7.
发色三肽底物测定血浆蛋白C活性及临床应用 总被引:2,自引:0,他引:2
建立了血浆蛋白C活性水平测定的发色三肽底物法,并对临床56例病例进行了检测。以正常人血浆蛋白C活性平均值为100%作对照,30例肝硬化病人血浆蛋白C活性平均为(61.4±27.3)%;7例慢性肾功能不全病人血浆蛋白C活性平均为(51.2±25.7)%,18例正常晚期妊娠妇女血浆蛋白C活性平均为(138.0±23.5)%。与正常对照组比较,结果差异均有显著性。在的1例血栓性血小板减少性紫癜(TTP) 相似文献
8.
Apolipoprotein B gene DNA polymorphisms are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus 总被引:2,自引:0,他引:2
Olavi Ukkola Markku J. Savolainen Pasi I. Salmela Kai von Dickhoff Y. Antero Kesäniemi 《Clinical genetics》1993,44(4):177-184
Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kesäniemi YA. Apolipoprotein B gene DNA polymorphisms are associated with macro-and microangiopathy in non-insulin-dependent diabetes mellitus. Clin Genet 1993: 44: 177–184. © Munksgaard, 1993 The relationship between diabetic macroangiopathy or microangiopathy and apolipoprotein B (apoB) polymorphism was studied in 139 male and 129 female patients with non-insulin-dependent diabetes (NIDDM) mellitus, comprising consecutive patients with poor diabetic control (HBA1 13.2%\pm2.7 (SD)) referred to our hospital. Plasma cholesterol and triglyceride concentrations were higher in the patients who were homozygous for the X2 allele (presence of Xba I cleavage site). Patients with the X1 allele (absence of Xba I cleavage site) tended to have a higher frequency of macroangiopathy, although the differences were not statistically significant. There was no difference in the prevalence of microangiopathy between the groups. In subjects with only an R1 allele (= R +; homozygous for the presence of EcoR I cleavage site) the prevalence of coronary heart disease (CHD) was observed to be high (61.9%) as compared to the subjects possessing an R2 allele (= R —; homozygous or heterozygous for the absence of the EcoR I cleavage site) (46.7%; p<0.02). When the polymorphisms Xba I (subjects homozygous for the absence of the cutting site = X +; subjects homozygous or heterozygous for the presence of the cutting site = X —) and EcoR I were combined, the prevalence of macroangiopathy was observed to be high in X + R + (80.0%) as compared with X + R- (44.2%), X-R+ (56.8%) and X-R- (50.0%) (p<0.03). The prevalence of macroangiopathy tended to be particularly high in patients with the apoprotein E4 allele (phenotype E4\4 or E4/3), combined with either X+ or R +. Our findings suggest that variation at the apoB locus is one of the factors involved in predisposing diabetic patients to the development of arterial disease. As in previous studies the effect of the variation at the apoB gene on circulating lipid levels was observed. The data also support a role for the e4 allele of the apolipoprotein E gene as an important determinant of macroangiopathy in NIDDM. 相似文献
9.
糖尿病及其并发症病是全世界关注的重大公共卫生问题。糖尿病微血管病变是糖尿病虚损夹血瘀形成的血管并发症,以微循环障碍并伴有透明样物质沉积为基本病理改变特征,糖尿病肾病、糖尿病视网膜病变和糖尿病神经病变最为常见。糖尿病微血管病变可追溯到糖尿病前期,随着糖尿病发生发展动态演进不断加重,需及早干预。临床在降糖、降脂、降压的基础治疗上,多选择抗氧化应激、抗炎、改善微循环和抗血管新生的药物治疗糖尿病微血管并发症。糖尿病微血管病变属于中医“络病”的概念,中药治疗糖尿病微血管病变的核心是在降糖的基础上保护“孙络-微血管”,组方多为补气滋阴、清热活血药味配伍而成。该文基于糖尿病微血管病变的中西医认识及治疗原则,简要概述针对不同证型治疗糖尿病微血管病变的常用方剂,如白虎加人参汤、玉液汤、四妙勇安汤、葛根芩连汤、六味地黄丸及一些现代制剂,同时概述方剂常用药味,如人参、黄芪、地黄、枸杞子、三七、丹参、金银花、葛根的研究进展,以期为中药治疗糖尿病微血管病变提供临床依据和理论指导。 相似文献
10.
血管紧张素转换酶和内皮素与糖尿病微血管病变的关系 总被引:9,自引:1,他引:8
目的 探讨血管紧张素转换酶(angiotensin converting enzyme,ACE)和血浆内皮素(endothelin,ET)水平与糖尿病微血管病变的关系。方法 用紫外分光光度法和直接放射免疫法测定55例糖尿病患者和30名正常人血清ACE和血浆ET水平。结果 糖尿病微血管病变患者血清ACE和血浆ET水平显著高于糖尿病无微血管病变患者,且随着糖尿病微血管病变的加重,血清ACE和血浆ET水平显著增高。糖尿病患者血清ACE和血浆ET水平呈显著正相关。结论 糖尿病微血管病变患者血清ACE和血清ET水平增高可能与糖尿病微血管病变的发生发展有关。 相似文献